Showing results (1531-1540 of 2,563) with videos related to
Sort By:
Pageof 257
Inflammopharmacology|July 28, 2007
An analysis from clinico-epidemiological data of the principal adverse events from the COX-2 selective NSAID, nimesulide, with particular reference to hepatic injuryK D RainsfordInflammopharmacology|July 28, 2007
Paracetamol-induced hepatotoxicity: lack of enhancement of the hepatoprotective effect of N-acetylcysteine by sodium sulphateA K Al-Ali, Z H Al-Mustafa, F S Qaw, et al.Inflammopharmacology|July 28, 2007
Effect of sulglycotide on the apoptotic processes associated with indomethacin-induced gastric mucosal injuryB L Slomiany, J Piotrowski, A SlomianyInflammopharmacology|July 28, 2007
Calculation of the antibiotic level in the lung tissue and bronchial secretion with an oral controlled-release dosage formM Saïdna, E M Ouriemchi, J M VergnaudInflammopharmacology|July 20, 2007
Current concepts of the actions of paracetamol (acetaminophen) and NSAIDsG G Graham, R O Day, M K Milligan, et al.Inflammopharmacology|July 20, 2007
Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicineM W Whitehouse, A G Turner, C K Davis, et al.Inflammopharmacology|July 20, 2007
The role of non-protein sulphydryls in the protective effects of antioxidants against ethanol-induced vascular permeability changes in the rat stomachA T Mobarok AliInflammopharmacology|July 20, 2007
The effects of piracetam on morphine-induced amnesia and analgesia: the possible contribution of central opiatergic mechanisms on the antiamnestic effect of piracetamF Aksu, I Gültekin, S Y Inan, et al.Inflammopharmacology|July 20, 2007
S(+)-ibuprofen (dexibuprofen)--Excellent tolerance has not to be combined with poor clinical efficacyA Zohmann, R Hawel, G Klein, et al.Inflammopharmacology|January 1, 1997
Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped musselM W Whitehouse, T A Macrides, N Kalafatis, et al.Pageof 257